| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6927 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
1997-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2001-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001504813-A |
| titleOfInvention |
Platelet substitutes and conjugation methods suitable for their production |
| abstract |
(57) [Summary]nA therapeutically useful platelet substitute containing fibrinogen, or the like, comprises an insoluble carrier to which is attached an essentially non-degraded active protein containing an RGD sequence. Such a conjugate can be prepared by a conjugation method so as to contain 0.01 to 2.5% by weight of active fibrinogen and 50% or less of inactive fibrinogen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017025065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011520913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005504745-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422362-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10035840-B2 |
| priorityDate |
1996-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |